These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 11965547
1. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T, Imai K. Oncogene; 2002 Apr 18; 21(17):2741-9. PubMed ID: 11965547 [Abstract] [Full Text] [Related]
2. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N. Oncol Rep; 2004 Nov 18; 12(5):1087-92. PubMed ID: 15492797 [Abstract] [Full Text] [Related]
3. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP. Cancer Res; 2000 Aug 01; 60(15):4044-8. PubMed ID: 10945606 [Abstract] [Full Text] [Related]
4. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Soejima H, Nakagawachi T, Zhao W, Higashimoto K, Urano T, Matsukura S, Kitajima Y, Takeuchi M, Nakayama M, Oshimura M, Miyazaki K, Joh K, Mukai T. Oncogene; 2004 May 27; 23(25):4380-8. PubMed ID: 15007390 [Abstract] [Full Text] [Related]
5. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, Shinomura Y. J Pathol; 2007 Oct 27; 213(2):131-9. PubMed ID: 17724792 [Abstract] [Full Text] [Related]
6. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Stirzaker C, Song JZ, Davidson B, Clark SJ. Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996 [Abstract] [Full Text] [Related]
7. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R. Carcinogenesis; 2004 May 01; 25(5):693-701. PubMed ID: 14729589 [Abstract] [Full Text] [Related]
8. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y, Matsukura S, Kudo S, Kitajima Y, Harada H, Furukawa K, Matsuzaki H, Emi M, Nakabeppu Y, Miyazaki K, Sekiguchi M, Mukai T. Oncogene; 2003 Dec 04; 22(55):8835-44. PubMed ID: 14647440 [Abstract] [Full Text] [Related]
9. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y, Fatima N, Dufau ML. Mol Cell Biol; 2005 Sep 04; 25(18):7929-39. PubMed ID: 16135786 [Abstract] [Full Text] [Related]
10. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W. J Pathol; 2005 Jan 04; 205(1):65-73. PubMed ID: 15586362 [Abstract] [Full Text] [Related]
11. Epigenetic inactivation of CHFR in human tumors. Toyota M, Sasaki Y, Satoh A, Ogi K, Kikuchi T, Suzuki H, Mita H, Tanaka N, Itoh F, Issa JP, Jair KW, Schuebel KE, Imai K, Tokino T. Proc Natl Acad Sci U S A; 2003 Jun 24; 100(13):7818-23. PubMed ID: 12810945 [Abstract] [Full Text] [Related]
12. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ. Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956 [Abstract] [Full Text] [Related]
13. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Bhakat KK, Mitra S. Carcinogenesis; 2003 Aug 15; 24(8):1337-45. PubMed ID: 12807730 [Abstract] [Full Text] [Related]
14. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C. J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832 [Abstract] [Full Text] [Related]
15. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R. Cancer Res; 2002 Jul 01; 62(13):3698-701. PubMed ID: 12097277 [Abstract] [Full Text] [Related]
16. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH. Cancer Res; 2003 Oct 01; 63(19):6178-86. PubMed ID: 14559801 [Abstract] [Full Text] [Related]
17. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T. Mol Carcinog; 2005 Dec 01; 44(4):233-41. PubMed ID: 16163707 [Abstract] [Full Text] [Related]
18. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. Agrelo R, Setien F, Espada J, Artiga MJ, Rodriguez M, Pérez-Rosado A, Sanchez-Aguilera A, Fraga MF, Piris MA, Esteller M. J Clin Oncol; 2005 Jun 10; 23(17):3940-7. PubMed ID: 15867203 [Abstract] [Full Text] [Related]